Found: 130
Select item for more details and to access through your institution.
Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 9, p. 2535, doi. 10.1093/rheumatology/keae180
- By:
- Publication type:
- Article
Correction: S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Urine biomarker score captures response to induction therapy with lupus nephritis.
- Published in:
- Pediatric Nephrology, 2023, v. 38, n. 8, p. 2679, doi. 10.1007/s00467-023-05888-z
- By:
- Publication type:
- Article
Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
- Published in:
- Pediatric Nephrology, 2019, v. 34, n. 1, p. 117, doi. 10.1007/s00467-018-4049-5
- By:
- Publication type:
- Article
School Support and Functioning for Children with Juvenile Rheumatic Diseases.
- Published in:
- Journal of Developmental & Physical Disabilities, 2007, v. 19, n. 2, p. 81, doi. 10.1007/s10882-007-9038-8
- By:
- Publication type:
- Article
Pain, Fatigue, Family Functioning, and Attitude Toward Illness in Children with Juvenile Rheumatic Diseases.
- Published in:
- Journal of Developmental & Physical Disabilities, 2007, v. 19, n. 2, p. 135, doi. 10.1007/s10882-006-9028-2
- By:
- Publication type:
- Article
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4568, doi. 10.1093/rheumatology/keab047
- By:
- Publication type:
- Article
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4495, doi. 10.1093/rheumatology/keab021
- By:
- Publication type:
- Article
170 Safety and efficacy of subcutaneous tocilizumab in patients with systemic and polyarticular juvenile idiopathic arthritis.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Discovery of SERPINA3 as a candidate urinary biomarker of lupus nephritis activity.
- Published in:
- Rheumatology, 2019, v. 58, n. 2, p. 321, doi. 10.1093/rheumatology/key301
- By:
- Publication type:
- Article
Land-Jump Performance in Patients with Juvenile Idiopathic Arthritis (JIA): A Comparison to Matched Controls.
- Published in:
- International Journal of Rheumatology, 2009, v. 2009, p. 1, doi. 10.1155/2009/478526
- By:
- Publication type:
- Article
Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis.
- Published in:
- Pediatric Rheumatology, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12969-018-0279-0
- By:
- Publication type:
- Article
Pediatric Rheumatology Collaborative Study Group – over four decades of pivotal clinical drug research in pediatric rheumatology.
- Published in:
- Pediatric Rheumatology, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12969-018-0261-x
- By:
- Publication type:
- Article
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.
- Published in:
- Pediatric Rheumatology, 2017, v. 15, p. 1, doi. 10.1186/s12969-017-0212-y
- By:
- Publication type:
- Article
Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).
- Published in:
- Pediatric Rheumatology, 2017, v. 15, p. 1, doi. 10.1186/s12969-017-0202-0
- By:
- Publication type:
- Article
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2016, v. 14, p. 1, doi. 10.1186/s12969-016-0071-y
- By:
- Publication type:
- Article
Relationship of cell-free urine MicroRNA with lupus nephritis in children.
- Published in:
- Pediatric Rheumatology, 2016, v. 14, p. 1, doi. 10.1186/s12969-016-0064-x
- By:
- Publication type:
- Article
Achieving consensus on quality indicators (QI) for pediatric Systemic Lupus Erythematosus (pSLE).
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE).
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Practice Analysis and Determining the Knowledge and Skills Expected of a Pediatric Rheumatologist.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 11, p. 619, doi. 10.1002/acr2.11613
- By:
- Publication type:
- Article
Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 10, p. 1856, doi. 10.1002/art.42534
- By:
- Publication type:
- Article
Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 3, p. 530, doi. 10.1002/art.41528
- By:
- Publication type:
- Article
Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 2, p. 336, doi. 10.1002/art.41488
- By:
- Publication type:
- Article
Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open‐Label, Active‐Treatment Extension Study.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 12, p. 2147, doi. 10.1002/art.41436
- By:
- Publication type:
- Article
New Medications Are Needed for Children With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 11, p. 1945, doi. 10.1002/art.41390
- By:
- Publication type:
- Article
Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1943, doi. 10.1002/art.41073
- By:
- Publication type:
- Article
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 3, p. 451, doi. 10.1002/art.40727
- By:
- Publication type:
- Article
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 9, p. 1508, doi. 10.1002/art.40509
- By:
- Publication type:
- Article
Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 7, p. 1144, doi. 10.1002/art.40466
- By:
- Publication type:
- Article
Brief Report: Novel UNC13D Intronic Variant Disrupting an NF‐κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 6, p. 963, doi. 10.1002/art.40438
- By:
- Publication type:
- Article
Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 1, p. 218, doi. 10.1002/art.39407
- By:
- Publication type:
- Article
Randomized, Double-Blind, Dose-Escalation Trial of Triptorelin for Ovary Protection in Childhood-Onset Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 5, p. 1377, doi. 10.1002/art.39024
- By:
- Publication type:
- Article
Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 3, p. 840, doi. 10.1002/art.38984
- By:
- Publication type:
- Article
Half-Life and Safety of Canakinumab in Pediatric Patients: Comment on the Article by Ilowite et al.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 3, p. 857, doi. 10.1002/art.38992
- By:
- Publication type:
- Article
A66: Assessment of Radiographic Progression in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab: 2-Year Results From the TENDER Trial.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S96, doi. 10.1002/art.38482
- By:
- Publication type:
- Article
A6: Tapering and Withdrawal of Tocilizumab in Patients With Systemic Juvenile Idiopathic Arthritis in Inactive Disease: Results From an Alternative Dosing Regimen in the TENDER Study.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S8, doi. 10.1002/art.38417
- By:
- Publication type:
- Article
A52: The Impact of Adalimumab on Growth in Patients With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S77, doi. 10.1002/art.38468
- By:
- Publication type:
- Article
A14: Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Systemic Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S23, doi. 10.1002/art.38430
- By:
- Publication type:
- Article
A134: Validation of Patient Reported Outomes Measurement Information System Modules for use in Childhood-;onset Lupus.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S176, doi. 10.1002/art.38555
- By:
- Publication type:
- Article
A54: Insulin Sensitivity Is Improved in sJIA Children With Insulin Resistance After Tocilizumab Treatment: Results From the TENDER Study.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S80, doi. 10.1002/art.38470
- By:
- Publication type:
- Article
A58: Demographics, Clinical Features and Therapies of Patients with Juvenile Dermatomyositis Participating in a National Myositis Patient Registry.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S86, doi. 10.1002/art.38474
- By:
- Publication type:
- Article
A22: Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis-Status of Use in Daily Clinical Care.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S35, doi. 10.1002/art.38438
- By:
- Publication type:
- Article
A33: Cognitive Performance Scores for the Pediatric Automated Neuropsychological Assessment Metrics in Childhood-Onset Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S51, doi. 10.1002/art.38449
- By:
- Publication type:
- Article
A133: Initial Benchmarking of the Quality of Medical Care of Children and Adolescents with Lupus.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S174, doi. 10.1002/art.38554
- By:
- Publication type:
- Article
A4: Efficacy and Safety of Tocilizumab in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From CHERISH.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S5, doi. 10.1002/art.38415
- By:
- Publication type:
- Article
A148: A Multi-Center, Double-Blind, Randomized-Withdrawal Trial of Subcutaneous Golimumab in Pediatric Patients With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: Week 48 Results.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S191, doi. 10.1002/art.38569
- By:
- Publication type:
- Article
A156: Pharmacokinetics and Pharmacogenetics of Mycophenolic Acid and Response to Therapy in Childhood-Onset Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S202, doi. 10.1002/art.38582
- By:
- Publication type:
- Article
A45: Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S67, doi. 10.1002/art.38461
- By:
- Publication type:
- Article
A171: Tocilizumab Dosing in Juvenile Idiopathic Arthritis: Optimizing for Different Juvenile Idiopathic Arthritis Type and Patient Body Weight.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S222, doi. 10.1002/art.38597
- By:
- Publication type:
- Article